Fluorotechnics appoints Mark Weller to head up their UK Sales and Marketing operation
Fluorotechnics announced the appointment of Mark Weller as head of their UK Sales team. According to the copmpany, Mark brings to Fluorotechnics a wealth of sales and technical experience, having served as a leading sales specialist and key-account manager for protein analysis at GE Healthcare (previously Amersham Biosciences and Pharmacia Biotech) for more than 16 years. In this capacity, he was responsible for a number of major healthcare, biotech and pharmaceutical accounts in the UK. Marks role at GE Healthcare combined sales, business development and field-based technical support, including presentations, demonstrations and training support. He was also instrumental in the organization of User days (an opportunity for users to give presentations and to network) and seminars.
Fluorotechnics recently acquired the European electrophoresis company-ETC Elektrophorese Technik, to expand their product portfolio in protein and DNA analysis.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Protein analytics
Protein analytics provides a deep insight into these complex macromolecules, their structure, function and interactions. It is essential for discovering and developing biopharmaceuticals, understanding disease mechanisms, and identifying therapeutic targets. Techniques such as mass spectrometry, Western blot and immunoassays allow researchers to characterize proteins at the molecular level, determine their concentration and identify possible modifications.
Topic world Protein analytics
Protein analytics provides a deep insight into these complex macromolecules, their structure, function and interactions. It is essential for discovering and developing biopharmaceuticals, understanding disease mechanisms, and identifying therapeutic targets. Techniques such as mass spectrometry, Western blot and immunoassays allow researchers to characterize proteins at the molecular level, determine their concentration and identify possible modifications.
